Fostemsavir
Back to searchMolecule Structure
Scientific Name
Fostemsavir
Description of the Drug
Fostemsavir is an antiretroviral HIV-1 attachment inhibitor targeted against the gp120 subunit within the HIV-1 gp160 envelope glycoprotein.
Source: DrugBank Online – DrugBank.com. Retrieved 2023-03-10 from
http://www.drugbank.ca/drugs/DB11796
http://www.drugbank.ca/drugs/DB11796
Brand Name(s)
Not Available
Company Owner(s)
Viiv Healthcare Co
Mechanism(s) Of Action
| Target Name | Target Type | Action Type | Target ChEMBL ID |
|---|---|---|---|
| Envelope polyprotein GP160 | SINGLE PROTEIN | INHIBITOR | CHEMBL3520 |
Clinical Trial(s)
Unichem Links
| SureChEMBL | SCHEMBL754395 | |
| Human Metabolome Database | HMDB0252472 | |
| DrugBank | DB11796 | |
| PubChem: Thomson Pharma | 16408524 | |
| PubChem | 11319217 | |
| Nikkaji | J2.933.503F | |
| EPA CompTox Dashboard | DTXSID40235596 | |
| DrugCentral | 5401 | |
| ChemicalBook | CB32666601 | |
| Guide to Pharmacology | 11100 | |
| rxnorm | FOSTEMSAVIR | FOSTEMSAVIR TROMETHAMINE |
| ZINC | ZINC000014210883 |
